Skip to content

Clinical trials

Completed Phase 3 Overweight trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Phase 3 Status: Completed Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20052
20063
20075
20082
20093
20102
20115
20123
20133
20142
20162
20172
20186
20194
20202
20216
20223
202315
20247
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S17
Eli Lilly and Company15
Orexigen Therapeutics, Inc5
InQpharm Group3
University of Wisconsin, Madison2
Yonsei University2
Association Francaise pour la Recherche Thermale1
AstraZeneca1
Baylor College of Medicine1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight81
Obesity74
Diabetes Mellitus, Type 211
Weight Loss11
Nutrition Disorders7
Hypertension3
Insulin Resistance3
Obesity, Abdominal3
Prediabetic State3
Body Weight2

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.